These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17869149)

  • 1. Pulmonary versus systemic delivery of levofloxacin. The isolated lung of the rat as experimental approach for assessing pulmonary inhalation.
    Valle MJ; González López F; Sánchez Navarro A
    Pulm Pharmacol Ther; 2008; 21(2):298-303. PubMed ID: 17869149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary versus systemic delivery of antibiotics: comparison of vancomycin dispositions in the isolated rat lung.
    de Jesús Valle MJ; López FG; Hurlé AD; Navarro AS
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3771-4. PubMed ID: 17682107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of linezolid in the isolated rat lung after systemic and pulmonary drug delivery.
    de Jesús Valle MJ; Uranga NS; López FG; Hurlé AD; Navarro AS
    J Antimicrob Chemother; 2007 Nov; 60(5):1074-9. PubMed ID: 17827144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary disposition of vancomycin nebulized as lipid vesicles in rats.
    de Jesús Valle MJ; González JG; López FG; Navarro AS
    J Antibiot (Tokyo); 2013 Aug; 66(8):447-51. PubMed ID: 23677032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the disposition of levofloxacin, netilmicin and cefepime in the isolated rat lung.
    Martínez Martínez MS; Gandarillas CI; Martínez Lanao J; Sánchez Navarro A
    J Pharm Pharmacol; 2005 Jul; 57(7):861-7. PubMed ID: 15969945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
    Conte JE; Golden JA; McIver M; Zurlinden E
    Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
    Conte JE; Golden JA; McIver M; Little E; Zurlinden E
    Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750 mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis.
    Nicolau DP; Sutherland C; Winget D; Baughman RP
    Pulm Pharmacol Ther; 2012 Feb; 25(1):94-8. PubMed ID: 22210007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of flow rate on the disposition of levofloxacin and netilmicin in the isolated rat lung.
    Santos Martínez Martínez M; Colino Gandarillas CI; Lanao JM; Sánchez Navarro A
    Eur J Pharm Sci; 2005 Mar; 24(4):325-32. PubMed ID: 15734299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis.
    Hwang SM; Kim DD; Chung SJ; Shim CK
    J Control Release; 2008 Jul; 129(2):100-6. PubMed ID: 18538437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study testing whether concentrations of levofloxacin in interstitial space fluid of soft tissues may serve as a surrogate for predicting its pharmacokinetics in lung.
    Zeitlinger MA; Traunmüller F; Abrahim A; Müller MR; Erdogan Z; Müller M; Joukhadar C
    Int J Antimicrob Agents; 2007 Jan; 29(1):44-50. PubMed ID: 17189094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tear concentration and safety of levofloxacin ophthalmic solution 1.5% compared with ofloxacin ophthalmic solution 0.3% after topical administration in healthy adult volunteers.
    Walters T; Rinehart M; Krebs W; Holdbrook M
    Cornea; 2010 Mar; 29(3):263-8. PubMed ID: 20098307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery of levofloxacin-liposomes for the treatment of pulmonary inflammation.
    Zhang X; Sun P; Bi R; Wang J; Zhang N; Huang G
    J Drug Target; 2009 Jun; 17(5):399-407. PubMed ID: 19263265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver tissue concentrations of levofloxacin after single intravenous administration of 500 mg for antibiotic prophylaxis in liver surgery.
    Weinrich M; Scheingraber S; Stremovskaia T; Schilling MK; Kees F; Pistorius GA
    Int J Antimicrob Agents; 2006 Sep; 28(3):221-5. PubMed ID: 16904875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased anterior chamber penetration of topical levofloxacin 0.5% after pulsed dosing in cataract patients.
    Sundelin K; Seal D; Gardner S; Ropo A; Geldsetzer K; Lokkila J; Stenevi U
    Acta Ophthalmol; 2009 Mar; 87(2):160-5. PubMed ID: 18771480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung microdialysis study of levofloxacin in rats following intravenous infusion at steady state.
    Marchand S; Frasca D; Dahyot-Fizelier C; Breheret C; Mimoz O; Couet W
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3074-7. PubMed ID: 18591278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of intravenously administered levofloxacin in men and women.
    Overholser BR; Kays MB; Lagvankar S; Goldman M; Mueller BA; Sowinski KM
    Pharmacotherapy; 2005 Oct; 25(10):1310-8. PubMed ID: 16185174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue and serum levofloxacin concentrations in diabetic foot infection patients.
    Oberdorfer K; Swoboda S; Hamann A; Baertsch U; Kusterer K; Born B; Hoppe-Tichy T; Geiss HK; von Baum H
    J Antimicrob Chemother; 2004 Oct; 54(4):836-9. PubMed ID: 15375105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of optimized bronchoalveolar lavage sampling designs for characterization of pulmonary drug distribution.
    Clewe O; Karlsson MO; Simonsson US
    J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):699-708. PubMed ID: 26316105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.